SCHEMBL904236

SCHEMBL904236

CCN(CC)Cc1cc(F)c(F)cc1-c1ccc2nc(N)nc(C(=O)N3Cc4ccccc4C3)c2c1

nearest known ligand 0.68

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 12/20 0.68
HSP90AB1 P08238 4/20 0.55
ALDH1A1 P00352 1/20 0.37
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
SLC2A1 P11166 1/20 0.34
ICMT O60725 1/20 0.34
AVPR1B P47901 1/20 0.33
ROCK2 O75116 1/20 0.33
NAMPT P43490 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL904225 0.93 HSP90AA1 (0.68) HSP90AA1HSP90AB1SLC2A1
SCHEMBL904215 0.91 HSP90AA1 (0.63) HSP90AA1HSP90AB1ALDH1A1ADORA2AADORA1
SCHEMBL904221 0.90 HSP90AA1 (0.76) HSP90AA1HSP90AB1ALDH1A1ADORA2AADORA1
SCHEMBL904197 0.88 HSP90AA1 (0.66) HSP90AA1HSP90AB1
SCHEMBL904127 0.88 HSP90AA1 (0.74) HSP90AA1HSP90AB1ADORA2AADORA1
SCHEMBL903952 0.88 HSP90AA1 (0.79) HSP90AA1HSP90AB1
SCHEMBL904070 0.87 HSP90AA1 (0.73) HSP90AA1HSP90AB1ADORA2AADORA1
SCHEMBL15091337 0.87 HSP90AA1 (0.66) HSP90AA1HSP90AB1ADORA2AADORA1
SCHEMBL15091327 0.86 HSP90AA1 (0.64) HSP90AA1HSP90AB1ADORA2AADORA1
SCHEMBL10254791 0.86 HSP90AA1 (0.64) HSP90AA1HSP90AB1ALDH1A1ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621919-B1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GMBH (DE) 2016-01-13 EP claimed
EP-2621919-B1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GMBH (DE) 2016-01-13 EP disclosed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
WO-2012041435-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES HSP90B1, HSP90AB1, HSP90AA1 HSP90AA1 3/4885HSP90AB1 2/4885ALDH1A1 2843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.